QS Investors’s Acorda Therapeutics ACOR Stock Holding History

QS Investors’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,540	Closed	-$247K	–	1255
2021 Q1	$247K	Buy	2,540 +2,364	+1,343%	+$290K	﹤0.01%	1043
2020 Q4	$15K	Hold	176	–	–	﹤0.01%	1166
2020 Q3	$11K	Sell	176 -650	-79%	-$49K	﹤0.01%	1164
2020 Q2	$73K	Hold	826	–	–	﹤0.01%	1396
2020 Q1	$93K	Hold	826	–	–	﹤0.01%	1276
2019 Q4	$195K	Sell	826 -9	-1%	-$2.27K	﹤0.01%	1185
2019 Q3	$288K	Hold	835	–	–	﹤0.01%	1107
2019 Q2	$769K	Sell	835 -15	-2%	-$18.4K	0.01%	871
2019 Q1	$1.36M	Hold	850	–	–	0.01%	731
2018 Q4	$1.59M	Hold	850	–	–	0.02%	636
2018 Q3	$2M	Hold	850	–	–	0.02%	627
2018 Q2	$2.93M	Hold	850	–	–	0.03%	475
2018 Q1	$2.41M	Sell	850 -33	-4%	-$98.8K	0.02%	518
2017 Q4	$2.27M	Sell	883 -36	-4%	-$102K	0.02%	569
2017 Q3	$2.61M	Hold	919	–	–	0.02%	518
2017 Q2	$2.17M	Hold	919	–	–	0.02%	567
2017 Q1	$2.32M	Hold	919	–	–	0.02%	553
2016 Q4	$2.07M	Hold	919	–	–	0.02%	603
2016 Q3	$2.3M	Hold	919	–	–	0.02%	617
2016 Q2	$2.81M	Hold	919	–	–	0.02%	560
2016 Q1	$2.92M	Buy	919 +4	+0.4%	+$16.6K	0.03%	547
2015 Q4	$4.7M	Buy	915 +372	+69%	+$1.63M	0.05%	406
2015 Q3	$1.73M	Hold	543	–	–	0.02%	654
2015 Q2	$2.17M	Hold	543	–	–	0.03%	599
2015 Q1	$2.17M	Buy	+543	New	+$2.49M	0.02%	580

Other funds holding ACOR

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

QS Investors's ACOR Position: Q2 2021 in Review

QS Investors sold out of Acorda Therapeutics (ACOR) in Q2 2021, closing a stake of 2,540 shares — an estimated $247K sold.

QS Investors first reported a position in ACOR in Q1 2015 and held it in 25 quarters. The position peaked at $4.7M in Q4 2015. 34 funds tracked by Wall St. Rank hold ACOR as of Q2 2021.

QS Investors reported no remaining Acorda Therapeutics position as of Q2 2021 after selling out during the quarter.
QS Investors sold 2,540 Acorda Therapeutics shares in Q2 2021, an estimated $247K.
QS Investors first reported a position in Acorda Therapeutics in Q1 2015 and held it in 25 quarters.
QS Investors's Acorda Therapeutics position peaked at $4.7M in Q4 2015.
34 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.